JCMAX
Price
$65.04
Change
+$0.16 (+0.25%)
Updated
Oct 17 closing price
Net Assets
5.71B
VIMSX
Price
$78.99
Change
+$0.14 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

JCMAX vs VIMSX

Header iconJCMAX vs VIMSX Comparison
Open Charts JCMAX vs VIMSXBanner chart's image
JPMorgan Mid Cap Equity A
Price$65.04
Change+$0.16 (+0.25%)
VolumeN/A
Net Assets5.71B
Vanguard Mid Cap Index Investor
Price$78.99
Change+$0.14 (+0.18%)
VolumeN/A
Net Assets201.28B
JCMAX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
JCMAX vs. VIMSX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCMAX is a StrongBuy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 201B vs. JCMAX (5.71B). VIMSX pays higher dividends than JCMAX: VIMSX (1.36) vs JCMAX (0.21). JCMAX was incepted earlier than VIMSX: JCMAX (16 years) vs VIMSX (27 years). JCMAX (1.20) is less costly to investors than VIMSX (0.17). JCMAX is a more actively managed with annual turnover of: 61.00 vs. VIMSX (16.00). JCMAX has a lower initial minimum investment than VIMSX: JCMAX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 7.57 vs. JCMAX (-0.01). VIMSX return over 5 years is better than : 57.21 vs. JCMAX (21.96).
JCMAXVIMSXJCMAX / VIMSX
Total Expense Ratio1.090.17641%
Annual Report Gross Expense Ratio1.200.17706%
Fund Existence16 years27 years-
Gain YTD5.0229.69552%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets5.71B201B3%
Annual Yield % from dividends0.211.3616%
Returns for 1 year-0.017.57-0%
Returns for 3 years35.6249.6572%
Returns for 5 years21.9657.2138%
Returns for 10 years47.41140.6034%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIHL17.910.24
+1.36%
Fidelis Insurance Holdings Limited
ABVC2.92N/A
N/A
ABVC BioPharma
BAYAU11.35N/A
N/A
Bayview Acquisition Corp
GBLI29.00N/A
-0.02%
Global Indemnity Group LLC
PEN249.00-4.84
-1.91%
Penumbra